NEW YORK, NY / ACCESSWIRE / August 15, 2018 /U.S. equities snapped losses on Tuesday, as panic over Turkey’s currency eased and market participants focused on upbeat corporate earnings and strong economic data. The NFIB’s (National Federation of Independent Business) small-business optimism index rose 0.7 points in July, its 2nd-highest level ever. The Dow Jones Industrial Average increased 0.45
“I think that you’re getting a bounce today because of the action of the past couple of days,” according to Robert Pavlik,
RDI Initiates Coverage on:
Spark Therapeutics, Inc.
PTC Therapeutics, Inc.
Spark Therapeutics' stock jumped 4.87% Tuesday, to close the day at $61.35. The stock recorded a trading volume of 673,784 shares, which was below its three months average volume of 690,531 shares. In the last year, Spark Therapeutics' shares have traded in a range of 41.06 - 96.59. The share price has gained 49.42% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $79.09 is above its 200-day moving average of $71.76. Shares of Spark Therapeutics have fallen roughly 27.8
Access RDI's Spark Therapeutics, Inc. Research Report at:
On Tuesday, shares of PTC Therapeutics recorded a trading volume of 724,752 shares, which was below the three months average volume of 1,301,814 shares. The stock ended the day 4.06% higher at $44.89. The share price has fallen 15.22% from its 52
Access RDI's PTC Therapeutics, Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.